 | • レポートコード：MRC23Q36036 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のGMP細胞バンキング市場について調査・分析し、世界のGMP細胞バンキング市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（哺乳類細胞、微生物細胞、昆虫細胞、その他）、用途別セグメント分析（バイオ製薬会社、受託製造会社）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Charles River、Thermo Fisher、Lonza、Wuxi Apptec、Eurofins Scientific、Merck KGaA、SGS Life Sciences、Sartorius、Catalent、Goodwin Biotechnology、Texcellなどが含まれています。世界のGMP細胞バンキング市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、GMP細胞バンキング市場規模を推定する際に考慮しました。本レポートは、GMP細胞バンキングの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、GMP細胞バンキングに関するビジネス上の意思決定に役立てることを目的としています。 ・GMP細胞バンキング市場の概要 - GMP細胞バンキングのタイプ別セグメント - 世界のGMP細胞バンキング市場規模：タイプ別分析（哺乳類細胞、微生物細胞、昆虫細胞、その他） - GMP細胞バンキングの用途別セグメント - 世界のGMP細胞バンキング市場規模：用途別分析（バイオ製薬会社、受託製造会社） - 世界のGMP細胞バンキング市場規模予測（2018年-2029年） ・GMP細胞バンキング市場の成長トレンド - GMP細胞バンキングの地域別市場規模（2018年-2029年） - GMP細胞バンキング市場ダイナミクス - GMP細胞バンキングの業界動向 - GMP細胞バンキング市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：哺乳類細胞、微生物細胞、昆虫細胞、その他 - 世界のGMP細胞バンキングのタイプ別市場規模（2018年-2023年） - 世界のGMP細胞バンキングのタイプ別市場規模（2024年-2029年） ・用途別セグメント：バイオ製薬会社、受託製造会社 - 世界のGMP細胞バンキングの用途別市場規模（2018年-2023年） - 世界のGMP細胞バンキングの用途別市場規模（2024年-2029年） ・GMP細胞バンキングの地域別市場規模 - 北米のGMP細胞バンキング市場規模（2018年-2029年） - アメリカのGMP細胞バンキング市場規模（2018年-2029年） - ヨーロッパのGMP細胞バンキング市場規模（2018年-2029年） - アジア太平洋のGMP細胞バンキング市場規模（2018年-2029年） - 中国のGMP細胞バンキング市場規模（2018年-2029年） - 日本のGMP細胞バンキング市場規模（2018年-2029年） - 韓国のGMP細胞バンキング市場規模（2018年-2029年） - インドのGMP細胞バンキング市場規模（2018年-2029年） - オーストラリアのGMP細胞バンキング市場規模（2018年-2029年） - 中南米のGMP細胞バンキング市場規模（2018年-2029年） - 中東・アフリカのGMP細胞バンキング市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Charles River、Thermo Fisher、Lonza、Wuxi Apptec、Eurofins Scientific、Merck KGaA、SGS Life Sciences、Sartorius、Catalent、Goodwin Biotechnology、Texcell ・アナリストの観点/結論 ・調査方法とデータソース |
Cell banking systems are set up to assure that a uniform population of cells is preserved, their integrity is maintained, and a sufficient supply of material is accessible for the life of the product. Biosafety testing is performed on cell lines at multiple passages. A cell bank comprises of a storage facility for cells extracted from different body fluids and organ tissue so that they can be used in the future. Stored cells contain detailed characterization of the cell line thereby decreasing chances of cross contamination. And GMP cell banking services consists of outsourcing gathering, storing, characterization, and testing facilities of cell lines, tissues, and cells. GMP basically stands for “Good Manufacturing Practice.”
Highlights
The global GMP Cell Banking market was valued at US$ 644.2 million in 2022 and is anticipated to reach US$ 1289.3 million by 2029, witnessing a CAGR of 12.3% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of GMP cell banking include Charles River, Thermo Fisher, Lonza, Wuxi Apptec, etc. Global top five manufacturers hold a share over 55%. In terms of product, mammalian cell is the largest segment, with a share over 63%. And in terms of application, the largest application is biopharmaceutical companies, with a share over 75%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for GMP Cell Banking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Cell Banking.
The GMP Cell Banking market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global GMP Cell Banking market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GMP Cell Banking companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Charles River
Thermo Fisher
Lonza
Wuxi Apptec
Eurofins Scientific
Merck KGaA
SGS Life Sciences
Sartorius
Catalent
Goodwin Biotechnology
Texcell
Segment by Type
Mammalian Cell
Microbial Cell
Insect Cell
Others
Segment by Application
Biopharmaceutical Companies
Contract Manufacturing Organizations
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Cell Banking companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GMP Cell Banking Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Mammalian Cell
1.2.3 Microbial Cell
1.2.4 Insect Cell
1.2.5 Others
1.3 Market by Application
1.3.1 Global GMP Cell Banking Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biopharmaceutical Companies
1.3.3 Contract Manufacturing Organizations
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global GMP Cell Banking Market Perspective (2018-2029)
2.2 GMP Cell Banking Growth Trends by Region
2.2.1 Global GMP Cell Banking Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 GMP Cell Banking Historic Market Size by Region (2018-2023)
2.2.3 GMP Cell Banking Forecasted Market Size by Region (2024-2029)
2.3 GMP Cell Banking Market Dynamics
2.3.1 GMP Cell Banking Industry Trends
2.3.2 GMP Cell Banking Market Drivers
2.3.3 GMP Cell Banking Market Challenges
2.3.4 GMP Cell Banking Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GMP Cell Banking Players by Revenue
3.1.1 Global Top GMP Cell Banking Players by Revenue (2018-2023)
3.1.2 Global GMP Cell Banking Revenue Market Share by Players (2018-2023)
3.2 Global GMP Cell Banking Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by GMP Cell Banking Revenue
3.4 Global GMP Cell Banking Market Concentration Ratio
3.4.1 Global GMP Cell Banking Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GMP Cell Banking Revenue in 2022
3.5 GMP Cell Banking Key Players Head office and Area Served
3.6 Key Players GMP Cell Banking Product Solution and Service
3.7 Date of Enter into GMP Cell Banking Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GMP Cell Banking Breakdown Data by Type
4.1 Global GMP Cell Banking Historic Market Size by Type (2018-2023)
4.2 Global GMP Cell Banking Forecasted Market Size by Type (2024-2029)
5 GMP Cell Banking Breakdown Data by Application
5.1 Global GMP Cell Banking Historic Market Size by Application (2018-2023)
5.2 Global GMP Cell Banking Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America GMP Cell Banking Market Size (2018-2029)
6.2 North America GMP Cell Banking Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America GMP Cell Banking Market Size by Country (2018-2023)
6.4 North America GMP Cell Banking Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GMP Cell Banking Market Size (2018-2029)
7.2 Europe GMP Cell Banking Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe GMP Cell Banking Market Size by Country (2018-2023)
7.4 Europe GMP Cell Banking Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GMP Cell Banking Market Size (2018-2029)
8.2 Asia-Pacific GMP Cell Banking Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific GMP Cell Banking Market Size by Region (2018-2023)
8.4 Asia-Pacific GMP Cell Banking Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GMP Cell Banking Market Size (2018-2029)
9.2 Latin America GMP Cell Banking Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America GMP Cell Banking Market Size by Country (2018-2023)
9.4 Latin America GMP Cell Banking Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GMP Cell Banking Market Size (2018-2029)
10.2 Middle East & Africa GMP Cell Banking Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa GMP Cell Banking Market Size by Country (2018-2023)
10.4 Middle East & Africa GMP Cell Banking Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River GMP Cell Banking Introduction
11.1.4 Charles River Revenue in GMP Cell Banking Business (2018-2023)
11.1.5 Charles River Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Detail
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher GMP Cell Banking Introduction
11.2.4 Thermo Fisher Revenue in GMP Cell Banking Business (2018-2023)
11.2.5 Thermo Fisher Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza GMP Cell Banking Introduction
11.3.4 Lonza Revenue in GMP Cell Banking Business (2018-2023)
11.3.5 Lonza Recent Development
11.4 Wuxi Apptec
11.4.1 Wuxi Apptec Company Detail
11.4.2 Wuxi Apptec Business Overview
11.4.3 Wuxi Apptec GMP Cell Banking Introduction
11.4.4 Wuxi Apptec Revenue in GMP Cell Banking Business (2018-2023)
11.4.5 Wuxi Apptec Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Detail
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific GMP Cell Banking Introduction
11.5.4 Eurofins Scientific Revenue in GMP Cell Banking Business (2018-2023)
11.5.5 Eurofins Scientific Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Detail
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA GMP Cell Banking Introduction
11.6.4 Merck KGaA Revenue in GMP Cell Banking Business (2018-2023)
11.6.5 Merck KGaA Recent Development
11.7 SGS Life Sciences
11.7.1 SGS Life Sciences Company Detail
11.7.2 SGS Life Sciences Business Overview
11.7.3 SGS Life Sciences GMP Cell Banking Introduction
11.7.4 SGS Life Sciences Revenue in GMP Cell Banking Business (2018-2023)
11.7.5 SGS Life Sciences Recent Development
11.8 Sartorius
11.8.1 Sartorius Company Detail
11.8.2 Sartorius Business Overview
11.8.3 Sartorius GMP Cell Banking Introduction
11.8.4 Sartorius Revenue in GMP Cell Banking Business (2018-2023)
11.8.5 Sartorius Recent Development
11.9 Catalent
11.9.1 Catalent Company Detail
11.9.2 Catalent Business Overview
11.9.3 Catalent GMP Cell Banking Introduction
11.9.4 Catalent Revenue in GMP Cell Banking Business (2018-2023)
11.9.5 Catalent Recent Development
11.10 Goodwin Biotechnology
11.10.1 Goodwin Biotechnology Company Detail
11.10.2 Goodwin Biotechnology Business Overview
11.10.3 Goodwin Biotechnology GMP Cell Banking Introduction
11.10.4 Goodwin Biotechnology Revenue in GMP Cell Banking Business (2018-2023)
11.10.5 Goodwin Biotechnology Recent Development
11.11 Texcell
11.11.1 Texcell Company Detail
11.11.2 Texcell Business Overview
11.11.3 Texcell GMP Cell Banking Introduction
11.11.4 Texcell Revenue in GMP Cell Banking Business (2018-2023)
11.11.5 Texcell Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details